<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(2)</volume><submitter>Gilbody S</submitter><funding>NIHR</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Older adults were more likely to be socially isolated during the COVID-19 pandemic, with increased risk of depression and loneliness. We aimed to investigate whether a behavioural activation intervention delivered via telephone could mitigate depression and loneliness in at-risk older people during the COVID-19 pandemic.&lt;h4>Methods&lt;/h4>BASIL+ (Behavioural Activation in Social Isolation) was a pragmatic randomised controlled trial conducted among patients recruited from general practices in England and Wales, and was designed to assess the effectiveness of behavioural activation in mitigating depression and loneliness among older people during the COVID-19 pandemic. Eligible participants were aged 65 years and older, socially isolated, with a score of 5 or higher on the P</pubmed_abstract><journal>The lancet. Healthy longevity</journal><pagination>e97-e107</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10834375</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial.</pubmed_title><pmcid>PMC10834375</pmcid><pubmed_authors>Gilbody S</pubmed_authors><pubmed_authors>Bailey D</pubmed_authors><pubmed_authors>Henry A</pubmed_authors><pubmed_authors>Atha L</pubmed_authors><pubmed_authors>Crosland S</pubmed_authors><pubmed_authors>Ryde E</pubmed_authors><pubmed_authors>Traviss-Turner G</pubmed_authors><pubmed_authors>Newbronner E</pubmed_authors><pubmed_authors>Brady S</pubmed_authors><pubmed_authors>Hollingsworth K</pubmed_authors><pubmed_authors>Hill A</pubmed_authors><pubmed_authors>Shearsmith L</pubmed_authors><pubmed_authors>Chew-Graham CA</pubmed_authors><pubmed_authors>Baird K</pubmed_authors><pubmed_authors>Fairhurst C</pubmed_authors><pubmed_authors>Sloan C</pubmed_authors><pubmed_authors>Burke L</pubmed_authors><pubmed_authors>Wang HI</pubmed_authors><pubmed_authors>Littlewood E</pubmed_authors><pubmed_authors>McMillan D</pubmed_authors><pubmed_authors>Webster J</pubmed_authors><pubmed_authors>Gentry T</pubmed_authors><pubmed_authors>Coventry P</pubmed_authors><pubmed_authors>Hewitt C</pubmed_authors><pubmed_authors>BASIL trials collective</pubmed_authors><pubmed_authors>Ekers D</pubmed_authors><pubmed_authors>Woodhouse R</pubmed_authors><pubmed_authors>Clegg A</pubmed_authors><pubmed_authors>Lovell K</pubmed_authors><pubmed_authors>Pratt S</pubmed_authors><pubmed_authors>Dexter-Smith S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial.</name><description>&lt;h4>Background&lt;/h4>Older adults were more likely to be socially isolated during the COVID-19 pandemic, with increased risk of depression and loneliness. We aimed to investigate whether a behavioural activation intervention delivered via telephone could mitigate depression and loneliness in at-risk older people during the COVID-19 pandemic.&lt;h4>Methods&lt;/h4>BASIL+ (Behavioural Activation in Social Isolation) was a pragmatic randomised controlled trial conducted among patients recruited from general practices in England and Wales, and was designed to assess the effectiveness of behavioural activation in mitigating depression and loneliness among older people during the COVID-19 pandemic. Eligible participants were aged 65 years and older, socially isolated, with a score of 5 or higher on the P</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-26T03:17:42.457Z</modification><creation>2025-04-06T10:45:23.224Z</creation></dates><accession>S-EPMC10834375</accession><cross_references><pubmed>38310902</pubmed><doi>10.1016/S2666-7568(23)00238-6</doi></cross_references></HashMap>